# Gyre Therapeutics, Inc.: Form DEF 14A, filed Apr 21, 2025

- Company: [Gyre Therapeutics, Inc.](/companies/gyre.md) (CIK 1124105)
- Form: DEF 14A
- Filed: 2025-04-21
- Accepted by EDGAR: Apr 21, 2025, 21:23 ET
- Period: 2025-06-04
- Accession: 0001140361-25-014779
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm

Filed Apr 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-014779. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.